Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dysbiosis Impact on Lung Disease in HIV

NCT04155684 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT04155684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04155684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dysbiosis Impact on Lung Disease in HIV
Lead sponsor
University of Pittsburgh
Phase
Observational
Overall status
Completed
Start date
November 1, 2018
Completion date
October 1, 2022
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd, hiv infections, microbiome